Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSouth E.p.5.50% Regulatory News (52AF)

Share Price Information for South E.p.5.50% (52AF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 100.95
Bid: 98.15
Ask: 103.75
Change: -0.025 (-0.02%)
Spread: 5.60 (5.706%)
Open: 100.975
High: 0.00
Low: 0.00
Prev. Close: 100.975
52AF Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Indicative Results of Tender Offer

17 Sep 2014 11:00

RNS Number : 9115R
UK Power Networks Holdings Limited
17 September 2014
 

UK Power Networks Holdings Limited Announces Indicative Results of Tender Offer for the

£300,000,000 5.375 per cent. Senior Unsecured Fixed Rate Notes due November 2016

£250,000,000 5.125 per cent. Notes due 2023

£200,000,000 8.5 per cent. Notes due 2025

and £300,000,000 5.50 per cent. Notes due 2026

NOT FOR DISTRIBUTION IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES, ITS TERRITORIES AND POSSESSIONS (INCLUDING PUERTO RICO, THE U.S. VIRGIN ISLANDS, GUAM, AMERICAN SAMOA, WAKE ISLAND AND THE NORTHERN MARIANA ISLANDS), ANY STATE OF THE UNITED STATES OR THE DISTRICT OF COLUMBIA OR IN ANY OTHER JURISDICTION IN WHICH IT IS UNLAWFUL TO DISTRIBUTE THIS DOCUMENT

17 September 2014. UK Power Networks Holdings Limited (the Company) announces today the indicative results of its separate invitations to holders of the outstanding £300,000,000 5.375 per cent. Senior Unsecured Fixed Rate Notes due November 2016 of London Power Networks plc (the 2016 Notes), £250,000,000 5.125 per cent. Notes due 2023 of London Power Networks plc (the 2023 Notes), £200,000,000 8.5 per cent. Notes due 2025 of Eastern Power Networks plc (the 2025 Notes) and £300,000,000 5.50 per cent. Notes due 2026 of South Eastern Power Networks plc (the 2026 Notes and, together with the 2016 Notes, the 2023 Notes and the 2025 Notes, the Notes) to tender their Notes for purchase by the Company for cash (each such invitation an Offer and together the Offers).

The Offers were announced on 8 September 2014 and each Offer was made on the terms and subject to the conditions contained in the tender offer memorandum dated 8 September 2014 (the Tender Offer Memorandum) prepared by the Company. Capitalised terms used in this announcement but not defined have the meanings given to them in the Tender Offer Memorandum.

The Expiration Deadline for the Offers was 4.00 p.m. (London time) on 16 September 2014.

Total Cash Spend Amount and Final Acceptance Amount

In the event that the Company decides to accept valid tenders of Notes pursuant to the Offers, the Company expects to set the Total Cash Spend Amount at or around £188,670,855 and the Final Acceptance Amount at £150,001,000.

Indicative (Non-Binding) Results of the Offer for the 2016 Notes

As at the Expiration Deadline, £185,806,000 in aggregate nominal amount of 2016 Notes had been tendered for purchase pursuant to Non-Competitive Tender Instructions, and £21,007,000 in aggregate nominal amount of 2016 Notes had been tendered for purchase pursuant to Competitive Tender Instructions.

In the event that the Company decides to accept valid tenders of 2016 Notes pursuant to the relevant Offer, the Company expects to set the Series Acceptance Amount in respect of the 2016 Notes at £52,277,000. On the basis of the expected Series Acceptance Amount in respect of the 2016 Notes, the Company expects to set the 2016 Notes Purchase Spread at the Maximum Purchase Spread in respect of the 2016 Notes, being +50 bps. Accordingly, the Company expects to (i) accept for purchase all 2016 Notes tendered pursuant to valid Non-Competitive Tender Instructions with pro rata scaling at a Scaling Factor of 28.450 per cent., as further described in the Tender Offer Memorandum, and (ii) not accept for purchase any 2016 Notes tendered pursuant to valid Competitive Tender Instructions. Noteholders should note that this is a non-binding indication of the level at which the Company expects to set the Series Acceptance Amount in respect of the 2016 Notes and the Scaling Factor that would be applied as a consequence.

Indicative (Non-Binding) Results of the Offer for the 2023 Notes

As at the Expiration Deadline, £127,891,000 in aggregate nominal amount of 2023 Notes had been tendered for purchase pursuant to Non-Competitive Tender Instructions, and £34,780,000 in aggregate nominal amount of 2023 Notes had been tendered for purchase pursuant to Competitive Tender Instructions.

In the event that the Company decides to accept valid tenders of 2023 Notes pursuant to the relevant Offer, the Company expects to set the Series Acceptance Amount in respect of the 2023 Notes at £0. Accordingly, on the basis of the expected Series Acceptance Amount in respect of the 2023 Notes, the Company expects not to accept any 2023 Notes validly tendered pursuant to the relevant Offer.

Indicative (Non-Binding) Results of the Offer for the 2025 Notes

As at the Expiration Deadline, £67,721,000 in aggregate nominal amount of 2025 Notes had been tendered for purchase pursuant to Non-Competitive Tender Instructions, and £61,047,000 in aggregate nominal amount of 2025 Notes had been tendered for purchase pursuant to Competitive Tender Instructions.

In the event that the Company decides to accept valid tenders of 2025 Notes pursuant to the relevant Offer, the Company expects to set the Series Acceptance Amount in respect of the 2025 Notes at £67,721,000. On the basis of the expected Series Acceptance Amount in respect of the 2025 Notes, the Company expects to set the 2025 Notes Purchase Spread at the Maximum Purchase Spread in respect of the 2025 Notes, being +100 bps. Accordingly, the Company expects to (i) accept for purchase all 2025 Notes tendered pursuant to valid Non-Competitive Tender Instructions with no pro rata scaling and (ii) not accept for purchase any 2025 Notes tendered pursuant to valid Competitive Tender Instructions. Noteholders should note that this is a non-binding indication of the level at which the Company expects to set the Series Acceptance Amount in respect of the 2025 Notes.

Indicative (Non-Binding) Results of the Offer for the 2026 Notes

As at the Expiration Deadline, £69,816,000 in aggregate nominal amount of 2026 Notes had been tendered for purchase pursuant to Non-Competitive Tender Instructions, and £61,014,000 in aggregate nominal amount of 2026 Notes had been tendered for purchase pursuant to Competitive Tender Instructions.

In the event that the Company decides to accept valid tenders of 2026 Notes pursuant to the relevant Offer, the Company expects to set the Series Acceptance Amount in respect of the 2026 Notes at £30,003,000. On the basis of the expected Series Acceptance Amount in respect of the 2026 Notes, the Company expects to set the 2026 Notes Purchase Spread at the Maximum Purchase Spread in respect of the 2026 Notes, being +110 bps. Accordingly, the Company expects to (i) accept for purchase all 2026 Notes tendered pursuant to valid Non-Competitive Tender Instructions with pro rata scaling at a Scaling Factor of 43.000 per cent., as further described in the Tender Offer Memorandum, and (ii) not accept for purchase any 2026 Notes tendered pursuant to valid Competitive Tender Instructions. Noteholders should note that this is a non-binding indication of the level at which the Company expects to set the Series Acceptance Amount in respect of the 2026 Notes and the Scaling Factor that would be applied as a consequence.

Final Pricing for the Offers

Final pricing for the Offers will take place at or around 2.00 p.m. (London time) today, 17 September 2014 (the Pricing Time). As soon as practicable after the Pricing Time, the Company will announce whether it will accept valid tenders of Notes pursuant to any or all of the Offers and, if so accepted, the Total Cash Spend Amount, the Final Acceptance Amount, the Series Acceptance Amount for each Series of Notes so accepted, details of any pro rata scaling and the final pricing details for each Offer. The Settlement Date in respect of any Notes accepted for purchase is expected to be 19 September 2014.

HSBC Bank plc and RBC Europe Limited are acting as Dealer Managers for the Offers and Lucid Issuer Services Limited is acting as Tender Agent.

The Dealer Managers

HSBC Bank plc

8 Canada Square

London E14 5HQ

United Kingdom

 

 

Telephone: +44 20 7992 6237

Attention: Liability Management Group

Email: liability.management@hsbcib.com

RBC Europe Limited

Riverbank House

2 Swan Lane

London EC4R 3BF

United Kingdom

 

Telephone: +44 20 7029 7475

Attention: Liability Management Group

Email: liability.management@rbccm.com

The Tender Agent

Lucid Issuer Services Limited

Leroy House

436 Essex Road

London N1 3QP

United Kingdom

 

Telephone: +44 20 7704 0880

Attention: Paul Kamminga / David Shilson

Email: ukpn@lucid-is.com

DISCLAIMER This announcement must be read in conjunction with the Tender Offer Memorandum. No offer or invitation to acquire any Notes is being made pursuant to this announcement. The distribution of this announcement and the Tender Offer Memorandum in certain jurisdictions may be restricted by law. Persons into whose possession this announcement and/or the Tender Offer Memorandum comes are required by each of the Company, the Dealer Managers and the Tender Agent to inform themselves about, and to observe, any such restrictions.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TENUBOKRSAAKARR
Date   Source Headline
21st Feb 20241:15 pmRNSPublication of Suppl.Prospcts
20th Dec 202312:50 pmRNSPublication of Suppl.Prospcts
15th Dec 20234:50 pmRNSHalf-year Report
1st Aug 20231:26 pmRNSPublication of a Prospectus
17th Jul 20232:14 pmRNSAnnual Financial Report
2nd Jun 202312:52 pmRNSPublication of Final Terms (Series 2023-2)
25th May 20232:43 pmRNSPublication of Suppl.Prospcts
7th Dec 20225:27 pmRNSHalf-year Report
21st Sep 20225:09 pmRNSPublication of a Prospectus
28th Jul 20225:32 pmRNSAnnual Financial Report
8th Dec 20213:51 pmRNSHalf-year Report
30th Sep 20214:29 pmRNSPublication of Final Terms
22nd Jul 20212:54 pmRNSPublication of a Prospectus
15th Jul 20215:01 pmRNSAnnual Financial Report
8th Dec 20204:24 pmRNSHalf-year Report
5th Aug 20207:00 amRNSPublication of a Prospectus
24th Jul 20204:12 pmRNSAnnual Financial Report 31 March 2020
14th May 20204:46 pmRNSPublication of Suppl.Prospcts
6th Dec 20191:09 pmRNSHalf-year Interim Report
6th Aug 20194:09 pmRNSPublication of Suppl.Prospcts
25th Jul 20195:56 pmRNSAnnual Report 31 March 2019
16th Jul 201911:01 amRNSPublication of a Prospectus
11th Feb 20194:02 pmRNSPublication of Supplement to Prospectus
23rd Jan 20195:28 pmRNSPublication of Final Terms (Series 2011-1)
5th Dec 201812:23 pmRNSHalf-year Report
5th Sep 20185:48 pmRNSPublication of Final Terms Replacement
4th Sep 20184:57 pmRNSPublication of Final Terms
25th Jul 20184:42 pmRNSPublication of a Prospectus
19th Jul 20181:33 pmRNSAnnual Financial Report
15th Dec 20173:52 pmRNSHalf-year Interim Report
31st Aug 201712:27 pmRNSPublication of a Prospectus
9th Aug 201710:27 amRNSAnnual Financial Report
11th Feb 20155:00 pmRNSPublication of Final Terms
14th Nov 20145:38 pmRNSPublication of Offering Circular
14th Nov 20145:25 pmRNSPublication of Offering Circular
17th Sep 20143:34 pmRNSResults of Tender Offer
17th Sep 201411:00 amRNSIndicative Results of Tender Offer
8th Sep 20149:00 amRNSTender Offer
27th Sep 20126:15 pmRNSPublication of Offering Circular Replacement
27th Sep 20124:55 pmRNSPublication of Offering Circular
17th Jun 20115:04 pmRNSFinal Terms

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.